Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Front Mol Neurosci
2016 Feb 15;9:45. doi: 10.3389/fnmol.2016.00045.
Show Gene links
Show Anatomy links
Inter- and Intra-Subunit Butanol/Isoflurane Sites of Action in the Human Glycine Receptor.
McCracken ML
,
Gorini G
,
McCracken LM
,
Mayfield RD
,
Harris RA
,
Trudell JR
.
???displayArticle.abstract???
Glycine receptors (GlyRs) mediate inhibitory neurotransmission and are targets for alcohols and anesthetics in brain. GlyR transmembrane (TM) domains contain critical residues for alcohol/anesthetic action: amino acid A288 in TM3 forms crosslinks with TM1 (I229) in the adjacent subunit as well as TM2 (S267) and TM4 (Y406, W407, I409, Y410) in the same subunit. We hypothesized that these residues may participate in intra-subunit and inter-subunit sites of alcohol/anesthetic action. The following double and triple mutants of GLRA1 cDNA (encoding human glycine receptor alpha 1 subunit) were injected into Xenopus laevis oocytes: I229C/A288C, I229C/A288C/C290S, A288C/Y406C, A288C/W407C, A288C/I409C, and A288C/Y410C along with the corresponding single mutants and wild-type GLRA1. Butanol (22 mM) or isoflurane (0.6 mM) potentiation of GlyR-mediated currents before and after application of the cysteine crosslinking agent HgCl2 (10 μM) was measured using two-electrode voltage clamp electrophysiology. Crosslinking nearly abolished butanol and isoflurane potentiation in the I229C/A288C and I229C/A288C/C290S mutants but had no effect in single mutants or wild-type. Crosslinking also inhibited butanol and isoflurane potentiation in the TM3-4 mutants (A288C/Y406C, A288C/W407C, A288C/I409C, A288C/Y410C) with no effect in single mutants or wild-type. We extracted proteins from oocytes expressing I229C/288C, A288C/Y410C, or wild-type GlyRs, used mass spectrometry to verify their expression and possible inter-subunit dimerization, plus immunoblotting to investigate the biochemical features of proposed crosslinks. Wild-type GlyR subunits measured about 50 kDa; after crosslinking, the dimeric/monomeric 100:50 kDa band ratio was significantly increased in I229C/288C but not A288C/Y410C mutants or wild-type, providing support for TM1-3 inter-subunit and TM3-4 intra-subunit crosslinking. A GlyR homology model based on the GluCl template provides further evidence for a multi-site model for alcohol/anesthetic interaction with human GLRA1.
Figure 1. Effect of crosslinking on alcohol/anesthetic responses in TM1-3 mutants. Potentiation of EC5−10 glycine responses by 22 mM butanol (A) or 0.6 mM isoflurane (B) before and after application of the crosslinking agent HgCl2. HgCl2 (10 μM) was applied to wild-type, single mutants, and I229C/A288C and I229C/A288C/C290S mutants in the presence of 100 mM glycine (i.e., the activated/desensitized state). Values represent mean ± SEM from 4 to 5 oocytes. Repeated measures t-tests were used to test differences between pre-and post-HgCl2 conditions (*P < 0.05 compared to the pre-HgCl2 condition for each receptor).
Figure 2. Effect of crosslinking on alcohol responses in TM3-4 mutants. Potentiation of EC5−10 glycine responses by 22 mM butanol before and after HgCl2. (A) HgCl2 (10 μM) was applied to wild-type, single mutants, and double mutants (A288C/W407C, A288C/Y410C) in the absence of glycine (i.e., the resting/closed state). (B) HgCl2 (10 μM) was applied to wild-type, single mutants, and double mutants (A288C/Y406C, A288C/I409C) in the presence of 100 mM glycine (activated/desensitized state). Values represent mean ± SEM from 4 to 5 oocytes. Data from wild-type and A288C receptors were combined across experiments and are represented in (A,B) and Figure 1A. Repeated measures t-tests were used to detect differences between the pre-and post-HgCl2 conditions (*P < 0.05 compared to the pre-HgCl2 condition for each receptor).
Figure 3. Effect of crosslinking on alcohol responses in TM3-4 mutants. Tracings showing the effect of 22 mM butanol before and after application of 10 μM HgCl2 on EC5−10 glycine-induced currents in individual oocytes expressing wild-type (A) or A288C/Y410C (B) GlyRs. The upper bars indicate butanol pre-application.
Figure 4. Effect of crosslinking on anesthetic responses in TM3-4 mutants. Potentiation of EC5−10 glycine responses by 0.6 mM isoflurane before and after HgCl2. (A) HgCl2 (10 μM) was applied to wild-type, double (A288C/W407C, A288C/Y410C), and single mutants in the absence of glycine (closed state). (B) HgCl2 (10 μM) was applied to wild-type, double (A288C/Y406C, A288C/I409C), and single mutants in the presence of 100 mM glycine (activated/desensitized state). Values represent mean ± SEM from 4 to 5 oocytes. Data from wild-type and A288C receptors were combined across experiments and are represented in (A,B) and Figure 1B. Repeated measures t-tests were used to detect differences between the pre-and post-HgCl2 conditions (*P < 0.05 compared to the pre-HgCl2 condition for each receptor).
Figure 5. Effect of crosslinking using H2O2 on maximal glycine responses in TM1-3 mutants. The oxidizing agent, H2O2 (0.5%), was applied in the presence of 100 mM glycine for 1 minute followed by a 15-min washout. The response to glycine was measured and then the reducing agent dithiothreitol (DTT, 10 mM) was applied for 3 min followed by a 15-min washout. Values represent mean ± SEM from 3 to 6 oocytes (one-way ANOVA with Tukey's post-hoc test, *P < 0.05).
Figure 6. Semiquantitative analysis of dimeric/monomeric band ratios resulting from uncrosslinked and crosslinked GlyRs. Crosslinking was obtained by applying 0.5% H2O2 by bath perfusion. Equal amounts of protein were extracted from oocytes, resolved by SDS-PAGE under non-reducing conditions, and transferred to a membrane where a GlyR alpha 1 antibody was used. Immunoblot images were processed using ImageJ64 software, and GLRA1-labeled band intensity was obtained for 50 and 100 kDa bands, which correspond to monomeric and dimeric GlyR subunits, respectively. Band intensities are reported as direct ratios (100:50 kDa). Immunoblot image analysis revealed a significant increase in the 100:50 kDa band ratio for the I229/A288C (TM1-3) double mutant after crosslinking, but not in the uncrosslinked mutant or in the corresponding wild-type samples. Conversely, no differences in the 100:50 kDa band ratios were detected between uncrosslinked (pre-H2O2) and crosslinked (post-H2O2) conditions for the A288C/Y410C (TM3-4) double mutant or in the corresponding wild-type samples. Statistically significant differences in band ratios between the pre-H2O2 and post-H2O2 conditions were measured and reported as a ratio (mean ± SEM; t-tests, *P < 0.05).
Figure 7. GLRA1 homology models based on GluCl showing TM3-4 intra-subunit and TM1-3 inter-subunit distances. (A) The enlarged boxed area of a GLRA1 subunit shows distances between the C-alpha atoms of cysteines substituted at A288 (TM3) and Y406, W407, I409, and Y410 (TM4) within the same subunit were 14.7, 11.6, 15.3, and 14.6 Å, respectively. (B) The enlarged boxed area of two GLRA1 subunits shows distances between the C-alpha and S-S atoms of adjacent subunits (rendered as backbone ribbons in red and purple) were 10.3 and 7.8 Å, respectively.
Baenziger,
3D structure and allosteric modulation of the transmembrane domain of pentameric ligand-gated ion channels.
2011, Pubmed
Baenziger,
3D structure and allosteric modulation of the transmembrane domain of pentameric ligand-gated ion channels.
2011,
Pubmed
Baer,
Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review.
2009,
Pubmed
Bali,
GABA-induced intersubunit conformational movement in the GABAA receptor alpha 1M1-beta 2M3 transmembrane subunit interface: experimental basis for homology modeling of an intravenous anesthetic binding site.
2009,
Pubmed
,
Xenbase
Beckstead,
Antagonism of inhalant and volatile anesthetic enhancement of glycine receptor function.
2001,
Pubmed
,
Xenbase
Berman,
The Protein Data Bank.
2000,
Pubmed
Bertaccini,
Predicting the transmembrane secondary structure of ligand-gated ion channels.
2002,
Pubmed
Bertaccini,
Homology modeling of a human glycine alpha 1 receptor reveals a plausible anesthetic binding site.
2005,
Pubmed
Bertaccini,
Modeling anesthetic binding sites within the glycine alpha one receptor based on prokaryotic ion channel templates: the problem with TM4.
2010,
Pubmed
Bocquet,
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation.
2009,
Pubmed
Borghese,
GABA(A) receptor transmembrane amino acids are critical for alcohol action: disulfide cross-linking and alkyl methanethiosulfonate labeling reveal relative location of binding sites.
2014,
Pubmed
,
Xenbase
Borghese,
Identification of an Inhibitory Alcohol Binding Site in GABAA ρ1 Receptors.
2016,
Pubmed
,
Xenbase
Borghese,
Mutation in neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes blocks ethanol action.
2003,
Pubmed
,
Xenbase
Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed
Crawford,
Evidence that ethanol acts on a target in Loop 2 of the extracellular domain of alpha1 glycine receptors.
2007,
Pubmed
,
Xenbase
Du,
Glycine receptor mechanism elucidated by electron cryo-microscopy.
2015,
Pubmed
Ernst,
Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function.
2005,
Pubmed
Fatima-Shad,
Anion permeation in GABA- and glycine-gated channels of mammalian cultured hippocampal neurons.
1993,
Pubmed
Franks,
Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian γ-aminobutyric acid type A receptors.
2015,
Pubmed
Gorini,
Proteomic approaches and identification of novel therapeutic targets for alcoholism.
2014,
Pubmed
Grenningloh,
Cloning and expression of the 58 kd beta subunit of the inhibitory glycine receptor.
1990,
Pubmed
,
Xenbase
Harris,
Ethanol's molecular targets.
2008,
Pubmed
Harrison,
Positive modulation of human gamma-aminobutyric acid type A and glycine receptors by the inhalation anesthetic isoflurane.
1993,
Pubmed
Harvey,
GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.
2004,
Pubmed
Harvey,
Glycine receptors containing the alpha4 subunit in the embryonic sympathetic nervous system, spinal cord and male genital ridge.
2000,
Pubmed
,
Xenbase
Heusser,
Functional validation of virtual screening for novel agents with general anesthetic action at ligand-gated ion channels.
2013,
Pubmed
,
Xenbase
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hilf,
A prokaryotic perspective on pentameric ligand-gated ion channel structure.
2009,
Pubmed
Howard,
Seeking structural specificity: direct modulation of pentameric ligand-gated ion channels by alcohols and general anesthetics.
2014,
Pubmed
Howard,
Structural basis for alcohol modulation of a pentameric ligand-gated ion channel.
2011,
Pubmed
,
Xenbase
Huang,
Crystal structure of human glycine receptor-α3 bound to antagonist strychnine.
2015,
Pubmed
Jenkins,
Evidence for a common binding cavity for three general anesthetics within the GABAA receptor.
2001,
Pubmed
Jonsson,
Changes in glycine receptor subunit expression in forebrain regions of the Wistar rat over development.
2012,
Pubmed
Legendre,
The glycinergic inhibitory synapse.
2001,
Pubmed
Li,
Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors.
2010,
Pubmed
Lobo,
Cross-linking of glycine receptor transmembrane segments two and three alters coupling of ligand binding with channel opening.
2004,
Pubmed
,
Xenbase
Lobo,
Accessibility to residues in transmembrane segment four of the glycine receptor.
2006,
Pubmed
Lobo,
Channel gating of the glycine receptor changes accessibility to residues implicated in receptor potentiation by alcohols and anesthetics.
2004,
Pubmed
,
Xenbase
Lobo,
Cross-linking of sites involved with alcohol action between transmembrane segments 1 and 3 of the glycine receptor following activation.
2008,
Pubmed
,
Xenbase
Lynch,
Molecular structure and function of the glycine receptor chloride channel.
2004,
Pubmed
Mascia,
Specific binding sites for alcohols and anesthetics on ligand-gated ion channels.
2000,
Pubmed
,
Xenbase
Mascia,
Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics.
1996,
Pubmed
,
Xenbase
McCracken,
Linking of Glycine Receptor Transmembrane Segments Three and Four Allows Assignment of Intrasubunit-Facing Residues.
2010,
Pubmed
,
Xenbase
Mihic,
Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors.
1997,
Pubmed
,
Xenbase
Molander,
Accumbal strychnine-sensitive glycine receptors: an access point for ethanol to the brain reward system.
2005,
Pubmed
Moraga-Cid,
Allosteric and hyperekplexic mutant phenotypes investigated on an α1 glycine receptor transmembrane structure.
2015,
Pubmed
Murail,
Molecular mechanism for the dual alcohol modulation of Cys-loop receptors.
2012,
Pubmed
Murail,
Microsecond simulations indicate that ethanol binds between subunits and could stabilize an open-state model of a glycine receptor.
2011,
Pubmed
Nury,
One-microsecond molecular dynamics simulation of channel gating in a nicotinic receptor homologue.
2010,
Pubmed
Otero-Cruz,
Tryptophan-scanning mutagenesis in the alphaM3 transmembrane domain of the muscle-type acetylcholine receptor. A spring model revealed.
2007,
Pubmed
,
Xenbase
Perdigão,
Unexpected features of the dark proteome.
2015,
Pubmed
Sauguet,
Structural basis for potentiation by alcohols and anaesthetics in a ligand-gated ion channel.
2013,
Pubmed
Soskine,
Crosslinking of membrane-embedded cysteines reveals contact points in the EmrE oligomer.
2002,
Pubmed
Stewart,
State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor.
2013,
Pubmed
,
Xenbase
Stewart,
Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.
2008,
Pubmed
,
Xenbase
Struthers,
G protein-coupled receptor activation: analysis of a highly constrained, "straitjacketed" rhodopsin.
2000,
Pubmed
Takahashi,
Functional correlation of fetal and adult forms of glycine receptors with developmental changes in inhibitory synaptic receptor channels.
1992,
Pubmed
,
Xenbase
Trudell,
Are sobriety and consciousness determined by water in protein cavities?
2004,
Pubmed
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
van den Pol,
Glycine and glycine receptor immunoreactivity in brain and spinal cord.
1988,
Pubmed
Yip,
A propofol binding site on mammalian GABAA receptors identified by photolabeling.
2013,
Pubmed
Yoluk,
Conformational gating dynamics in the GluCl anion-selective chloride channel.
2015,
Pubmed
Yoluk,
Stabilization of the GluCl ligand-gated ion channel in the presence and absence of ivermectin.
2013,
Pubmed
Zhong,
Photo-activated azi-etomidate, a general anesthetic photolabel, irreversibly enhances gating and desensitization of gamma-aminobutyric acid type A receptors.
2008,
Pubmed
,
Xenbase